Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Telaprolu KC"'
Autor:
Newton Andréo-Filho, Jeffrey E. Grice, Michael S. Roberts, J Gomes, Eman Abd, Patricia Santos Lopes, Krishna Telaprolu, Vânia Rodrigues Leite-Silva, F Forouz, C C Sales, Shereen A. Yousef
Publikováno v:
International journal of cosmetic scienceReferences. 43(1)
The permeation of hydrophilic molecules through the skin is still a challenge due to the barrier posed by stratum corneum, the outermost layer of the skin. Liposomes have frequently been used as carriers for different types of drugs and may also func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0be26cded4ff33e643d2d8c27d104233
https://pubmed.ncbi.nlm.nih.gov/32866296
https://pubmed.ncbi.nlm.nih.gov/32866296
Autor:
Krishna Telaprolu, Christofori M. R. R. Nastiti, Jeffrey E. Grice, Heather A. E. Benson, Yousuf H. Mohammed, Xiaowen Liang, Michael S. Roberts
Background: Pig skin is a widely acknowledged surrogate for human skin for in vitro/ex vivo skin penetration studies with application for small molecules and nanosystems. We have investigated the influence of biological factors such as age and anatom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b22b37c082abfdb54c88ca182e922fd
https://hdl.handle.net/11541.2/137674
https://hdl.handle.net/11541.2/137674
Autor:
Mittapelly N; Certara Predictive Technologies (CPT), Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, U.K., Djehizian A; Certara Predictive Technologies (CPT), Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, U.K., Telaprolu KC; Certara Predictive Technologies (CPT), Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, U.K., McNally K; Certara Predictive Technologies (CPT), Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, U.K., Puttrevu SK; Certara Predictive Technologies (CPT), Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, U.K., Arjmandi-Tash O; Certara Predictive Technologies (CPT), Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, U.K., Polak S; Certara Predictive Technologies (CPT), Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, U.K.; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland., Bois FY; Certara Predictive Technologies (CPT), Simcyp Division, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, U.K.
Publikováno v:
ACS applied bio materials [ACS Appl Bio Mater] 2024 Nov 18; Vol. 7 (11), pp. 7453-7465. Date of Electronic Publication: 2024 Oct 18.
Autor:
Mohammed YH; Therapeutics Research Centre, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia. y.mohammed@uq.edu.au.; School of Pharmacy, The University of Queensland, Woolloongabba, QLD, 4102, Australia. y.mohammed@uq.edu.au.; School of Pharmacy, The University of Queensland, Brisbane, 2102, Australia. y.mohammed@uq.edu.au., Namjoshi SN; Therapeutics Research Centre, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Telaprolu KC; Therapeutics Research Centre, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Jung N; Institute of Pharmaceutical Technology, Goethe University, Frankfurt, Germany., Shewan HM; School of Chemical Engineering, The University of Queensland, Brisbane, QLD, 4072, Australia., Stokes JR; School of Chemical Engineering, The University of Queensland, Brisbane, QLD, 4072, Australia., Benson HAE; Curtin Medical School, Curtin University, Perth, WA, Australia., Grice JE; Therapeutics Research Centre, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Raney SG; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA., Rantou E; Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA., Windbergs M; Institute of Pharmaceutical Technology, Goethe University, Frankfurt, Germany. windbergs@em.uni-frankfurt.de., Roberts MS; Therapeutics Research Centre, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia. m.roberts@uq.edu.au.; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia. m.roberts@uq.edu.au.; Therapeutics Research Centre, Basil Hetzel Institute for Translational Medical Research, The Queen Elizabeth Hospital, Adelaide, Australia. m.roberts@uq.edu.au.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Oct; Vol. 41 (10), pp. 2043-2056. Date of Electronic Publication: 2024 Sep 30.
Autor:
Thakur K; Simcyp Division, Certara UK Limited, Sheffield, UK., Telaprolu KC; Simcyp Division, Certara UK Limited, Sheffield, UK., Paterson D; Simcyp Division, Certara UK Limited, Sheffield, UK., Salem F; Simcyp Division, Certara UK Limited, Sheffield, UK.; Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, R&D, Stevenage, UK., Arora S; Simcyp Division, Certara UK Limited, Sheffield, UK.; Janssen Pharmaceutical, Companies of Johnson & Johnson, Beerse, Belgium., Polak S; Simcyp Division, Certara UK Limited, Sheffield, UK.; Chair of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jun; Vol. 90 (6), pp. 1428-1449. Date of Electronic Publication: 2024 Mar 07.
Autor:
Telaprolu KC; Therapeutics Research Centre, Frazer Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia., Grice JE; Therapeutics Research Centre, Frazer Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia., Mohammed YH; Therapeutics Research Centre, Frazer Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia.; School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia., Roberts MS; Therapeutics Research Centre, Frazer Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia.; UniSA-Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.; Therapeutics Research Centre, Basil Hetzel Institute for Translational Medical Research, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia.
Publikováno v:
Metabolites [Metabolites] 2023 Aug 09; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 09.
Autor:
Abd E; Therapeutics Research Centre, Translational Research Institute, Diamantina Institute, University of Queensland, 37 Kent Street, Woolloongabba, Qld., 4072, Australia., Gomes J; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Rua São Nicolau, 210, prédio de vidro, Diadema, SP, CEP 09913-030, Brazil., Sales CC; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Rua São Nicolau, 210, prédio de vidro, Diadema, SP, CEP 09913-030, Brazil., Yousef S; Therapeutics Research Centre, Translational Research Institute, Diamantina Institute, University of Queensland, 37 Kent Street, Woolloongabba, Qld., 4072, Australia.; Faculty of Pharmacy, Helwan University, Helwan, Cairo, 11795, Egypt., Forouz F; Therapeutics Research Centre, Translational Research Institute, Diamantina Institute, University of Queensland, 37 Kent Street, Woolloongabba, Qld., 4072, Australia., Telaprolu KC; Therapeutics Research Centre, Translational Research Institute, Diamantina Institute, University of Queensland, 37 Kent Street, Woolloongabba, Qld., 4072, Australia., Roberts MS; Therapeutics Research Centre, Translational Research Institute, Diamantina Institute, University of Queensland, 37 Kent Street, Woolloongabba, Qld., 4072, Australia.; Clinical and Health Sciences, City West Campus, Level 6 Cancer Research Institute (UniSA CRI), University of South Australia, North Terrace, Adelaide, S.A., 5000, Australia., Grice JE; Therapeutics Research Centre, Translational Research Institute, Diamantina Institute, University of Queensland, 37 Kent Street, Woolloongabba, Qld., 4072, Australia., Lopes PS; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Rua São Nicolau, 210, prédio de vidro, Diadema, SP, CEP 09913-030, Brazil., Leite-Silva VR; Therapeutics Research Centre, Translational Research Institute, Diamantina Institute, University of Queensland, 37 Kent Street, Woolloongabba, Qld., 4072, Australia.; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Rua São Nicolau, 210, prédio de vidro, Diadema, SP, CEP 09913-030, Brazil., Andréo-Filho N; Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Rua São Nicolau, 210, prédio de vidro, Diadema, SP, CEP 09913-030, Brazil.
Publikováno v:
International journal of cosmetic science [Int J Cosmet Sci] 2021 Feb; Vol. 43 (1), pp. 1-10. Date of Electronic Publication: 2020 Oct 02.
Autor:
Nastiti CMRR; School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Bentley, Washington, Australia.; Faculty of Pharmacy, Sanata Dharma University, Yogyakarta, Indonesia., Mohammed Y; Therapeutics Research Centre, Faculty of Medicine, University of Queensland Diamantina Institute, Woolloongabba, Queensland, Australia., Telaprolu KC; Therapeutics Research Centre, Faculty of Medicine, University of Queensland Diamantina Institute, Woolloongabba, Queensland, Australia., Liang X; Therapeutics Research Centre, Faculty of Medicine, University of Queensland Diamantina Institute, Woolloongabba, Queensland, Australia., Grice JE; Therapeutics Research Centre, Faculty of Medicine, University of Queensland Diamantina Institute, Woolloongabba, Queensland, Australia., Roberts MS; Therapeutics Research Centre, Faculty of Medicine, University of Queensland Diamantina Institute, Woolloongabba, Queensland, Australia.; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia.; Therapeutics Research Centre, Basil Hetzel Institute for Translational Medical Research, Queen Elizabeth Hospital, Adelaide, South Australia, Australia., Benson HAE; School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Bentley, Washington, Australia, h.benson@curtin.edu.au.
Publikováno v:
Skin pharmacology and physiology [Skin Pharmacol Physiol] 2019; Vol. 32 (4), pp. 182-191. Date of Electronic Publication: 2019 May 14.